HER2Know Logo
HER2Know Logo
  • Tumor Types
    • Welcome to the new, updated HER2Know

      We have expanded our resource library so you can now explore content on HER2 in tumors beyond breast.

      Looking for the original HER2Know breast cancer resources?

      • Breast Cancer
        • Breast Cancer Overview
        • Breast Cancer Resources
        • IHC Atlas
        • Pathologists' Perspectives
          • Clinical Case Reviews
          • Spotlight Series
        • Knowledge Check
      • Gastric Cancer
        • Gastric Cancer Overview
        • Gastric Cancer Resources
        • Gastric Cancer IHC Atlas
      • Other Solid Tumors
        • Other Solid Tumors Overview
        • Other Solid Tumors Resources
        • Other Solid Tumors IHC Atlas
       
  • Resources
  • IHC Atlas
  • Contributors
  • In the Know
  • Subscribe
  • TUMOR TYPES
  • Breast Cancer
    • Breast Cancer Overview
    • Breast Cancer Resources
    • IHC Atlas
    • Pathologists' perspectives
    • Clinical Case Reviews
    • Spotlight Series
    • Knowledge Check
  • Gastric Cancer
    • Gastric Cancer Overview
    • Gastric Cancer Resources
    • Gastric Cancer IHC Atlas
  • Other Solid Tumors
    • Other Solid Tumors Overview
    • Other Solid Tumors Resources
    • Other Solid Tumors IHC Atlas
  • Resources
  • IHC Atlas
  • Contributors
  • In the Know
  • Subscribe
  • Contributors
  • Michael Feldman

Michael Feldman

MD, PhD

Breast Pathologist Dr Michael Feldman

Chair of the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine

Dr. Feldman, MD, PhD, is a Chair of the Department of Pathology and Laboratory Medicine at Indiana University School of Medicine. His professional interests revolve around the development, integration, and adoption of information technologies in the discipline of pathology. One of his main areas of interest within this broad discipline is in the field of digital imaging. Alongside his team, he has been studying pathology imaging on several fronts, including interactions between pathology/radiology (radiopathogenomics of prostate cancer and breast carcinoma) and the development and utilization of computer assisted diagnostic algorithms for machine vision in prostate and breast cancer. More recently they have been developing deep learning methods for complex interrogation of pathology slides, both within the cancer domain as well as in cardiovascular and renal pathology. They have also been developing methods to apply multispectral imaging for the analysis of multiplexed immunohistochemistry and immunofluorescence to tissues, along with the development of a quantitative system for scoring and analyzing these studies at a cytometric level on surgical pathology slides. The efforts have been recognized by the national funding agencies of the National Institute of Health and Department of Defense, as well as industry sponsored projects.

“I appreciate the whole slide images and consensus scoring, particularly the breadth of what HER2 IHC 1+ can look like.”

HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry.

Resources featuring Dr. Michael Feldman

Close Filters Add Filters

Sort by:
Newest to Oldest
  • Newest to Oldest
Filters:

View more

Resources

Educational courses and supporting
materials, developed by your peers,
to help evolve your clinical practice
of HER2 IHC assessment.

Explore Resources
Her2know Logo

Quick Links

  • Subscribe
  • Resources
  • Contributors

 

Breast Cancer Links

  • Breast Cancer Overview
  • Breast Cancer Resources
  • IHC Atlas
  • Clinical Case Reviews
  • Spotlight Series
  • Knowledge Check

 

Gastric Cancer Links

  • Gastric Cancer Overview
  • Gastric Cancer Resources

About Us

  • Contact Us
  • Request Medical Follow-Up
  • AstraZeneca
  • AZ Medical
  • Daiichi Sankyo Company
  • DSI Medical
  • Your Privacy Choices

Legal

  • Privacy Notice
  • Cookie Preferences
  • Legal Notices & Terms of Use
  • Consumer Health Data Privacy Notice
.
Daiichi-Sankyo - AstraZeneca Footer

©2025 Daiichi Sankyo, Inc. and AstraZeneca
PP-US-8201a-2248, PP-US-8201a-1849, PP-US-8201a-2036, US-84238, US-93987, US-102659 11/25

HER2Know Logo

Request an AstraZeneca Medical Affairs Representative Follow-Up

Welcome to HER2Know

This website is intended to help healthcare professionals practicing in the United States find and access scientifically balanced, evidence-based, and peer-led information and professional resources in support of HER2 IHC evaluation. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. This information is provided for educational purposes only. It is not intended for use in the diagnosis or treatment of individual patients. Are you a healthcare professional practicing in the United States?

I am a Daiichi Sankyo Company or AstraZeneca authorized person

What is a Daiichi Sankyo Company or AstraZeneca authorized person?

This website is only intended for healthcare professionals practicing in the United States and authorized Daiichi Sankyo Company or AstraZeneca personnel. US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. This website is not intended for use by US Field Sales personnel. None of the content of this site should be directly linked or distributed without approval.

Self Certification Buttons
No, take me to AstraZeneca.com Self Certification Buttons